Nasdaq: SCTX
Scribe Therapeutics insiders
The officers, directors and 10% owners of Scribe Therapeutics Inc. who hold the most stock, valued at the live SCTX price.
$13.22
SCTX today −$830K (−5.91%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 4
- Their SCTX stock
- $35.6M
- Market value
- $298M
- Held by ranked insiders
- 11.9%
Insiders by value of SCTX holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | ELI LILLY & Co | 10% owner | 1,054,828 | $13.9M | 4.68% | Corporate |
| 2 | Jennifer A. Doudna | 10% owner | 603,547 | $8.0M | 2.68% | 9146th |
| 3 | Brett Staahl | 10% owner | 524,336 | $6.9M | 2.32% | 11486th |
| 4 | Benjamin Oakes | President, CEO | 506,602 | $6.7M | 2.25% | 11776th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Scribe Therapeutics; see each profile for the filing.